Company Overview
About RapidAI
RapidAI is a San Francisco-based healthcare AI company that develops clinical imaging analysis and workflow software for neurovascular, cardiac, and vascular diseases. The company originated from research at the Stanford Stroke Center and pioneered AI-powered CT perfusion analysis for ischemic stroke treatment decisions — providing physicians with automated, quantitative imaging assessments within minutes of a patient arriving at the hospital. Its technology enables faster, more consistent treatment decisions for time-critical conditions where every minute of delay increases irreversible brain damage.
Business Model & Competitive Advantage
RapidAI''s platform is used by over 2,500 hospitals in more than 100 countries and is backed by over 700 peer-reviewed clinical studies — making it among the most clinically validated AI systems in medical imaging. Its CT Perfusion analysis is the gold standard at 75% of all Comprehensive Stroke Centers in the United States. The company raised $75M in a Series C round led by Vista Credit Partners. In November 2025, RapidAI received five new FDA clearances for imaging modules covering large and medium vessel occlusion detection (Rapid LMVO), midline shift assessment (Rapid MLS), delta fusion imaging (Rapid DeltaFuse), oral hemorrhage detection (Rapid OH), and aortic analysis (Rapid Aortic) — significantly expanding its product breadth beyond stroke into broader vascular and neurovascular disease management.
Competitive Landscape 2025–2026
RapidAI''s commercial model operates as a SaaS subscription sold to hospitals and health systems, with revenue tied to the number of cases analyzed. Its continuous FDA clearance expansion strategy adds new disease states and imaging modalities to a single integrated platform, increasing hospital value and switching costs. As AI regulation for medical devices matures globally, RapidAI''s regulatory track record and clinical validation portfolio position it as a trusted partner for health systems seeking to deploy AI at the point of care.
Key Differentiators
Market Leader
RapidAI is recognized as a market leader in the Healthcare sector, demonstrating strong industry presence and customer trust.
Frequently Asked Questions
Similar Brands
PointClickCare
PointClickCare is North America's leading cloud-based software platform for the long-term and post-acute care (LTPAC) market, headquartered in Mississauga, Ontario, Canada. Founded in 1999, the compan
CoverMyMeds
CoverMyMeds is the largest prior authorization platform in the United States, operating a network that connects more than 750,000 providers, 75,000 pharmacies, and virtually all payers to streamline t
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Idexx Laboratories
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu
Revvity
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid
Compare RapidAI with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from RapidAI? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim RapidAI Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention RapidAI vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →